280 related articles for article (PubMed ID: 8052653)
21. Nuclear factor of activated T cells is associated with a mast cell interleukin 4 transcription complex.
Weiss DL; Hural J; Tara D; Timmerman LA; Henkel G; Brown MA
Mol Cell Biol; 1996 Jan; 16(1):228-35. PubMed ID: 8524300
[TBL] [Abstract][Full Text] [Related]
22. A conserved enhancer element that drives FGF4 gene expression in the embryonic myotomes is synergistically activated by GATA and bHLH proteins.
Iwahori A; Fraidenraich D; Basilico C
Dev Biol; 2004 Jun; 270(2):525-37. PubMed ID: 15183731
[TBL] [Abstract][Full Text] [Related]
23. PU.1 positively regulates GATA-1 expression in mast cells.
Takemoto CM; Brandal S; Jegga AG; Lee YN; Shahlaee A; Ying Y; Dekoter R; McDevitt MA
J Immunol; 2010 Apr; 184(8):4349-61. PubMed ID: 20304827
[TBL] [Abstract][Full Text] [Related]
24. Protein-DNA interactions in vivo of an erythroid-specific, human beta-globin locus enhancer.
Reddy PM; Shen CK
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8676-80. PubMed ID: 1924329
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the human platelet/endothelial cell adhesion molecule-1 promoter: identification of a GATA-2 binding element required for optimal transcriptional activity.
Gumina RJ; Kirschbaum NE; Piotrowski K; Newman PJ
Blood; 1997 Feb; 89(4):1260-9. PubMed ID: 9028949
[TBL] [Abstract][Full Text] [Related]
26. cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1.
Thompson CB; Wang CY; Ho IC; Bohjanen PR; Petryniak B; June CH; Miesfeldt S; Zhang L; Nabel GJ; Karpinski B
Mol Cell Biol; 1992 Mar; 12(3):1043-53. PubMed ID: 1545787
[TBL] [Abstract][Full Text] [Related]
27. Erythroid regulatory elements.
Raich N; Romeo PH
Stem Cells; 1993 Mar; 11(2):95-104. PubMed ID: 8096156
[TBL] [Abstract][Full Text] [Related]
28. Role of SCL/Tal-1, GATA, and ets transcription factor binding sites for the regulation of flk-1 expression during murine vascular development.
Kappel A; Schlaeger TM; Flamme I; Orkin SH; Risau W; Breier G
Blood; 2000 Nov; 96(9):3078-85. PubMed ID: 11049987
[TBL] [Abstract][Full Text] [Related]
29. Reduction of DNA binding activity of the GATA-1 transcription factor in the apoptotic process induced by overexpression of PU.1 in murine erythroleukemia cells.
Yamada T; Kihara-Negishi F; Yamamoto H; Yamamoto M; Hashimoto Y; Oikawa T
Exp Cell Res; 1998 Nov; 245(1):186-94. PubMed ID: 9828115
[TBL] [Abstract][Full Text] [Related]
30. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1.
Zhang P; Behre G; Pan J; Iwama A; Wara-Aswapati N; Radomska HS; Auron PE; Tenen DG; Sun Z
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8705-10. PubMed ID: 10411939
[TBL] [Abstract][Full Text] [Related]
31. Protein-protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA binding.
Eisbacher M; Holmes ML; Newton A; Hogg PJ; Khachigian LM; Crossley M; Chong BH
Mol Cell Biol; 2003 May; 23(10):3427-41. PubMed ID: 12724402
[TBL] [Abstract][Full Text] [Related]
32. Regulation of lymphoid-specific immunoglobulin mu heavy chain gene enhancer by ETS-domain proteins.
Nelsen B; Tian G; Erman B; Gregoire J; Maki R; Graves B; Sen R
Science; 1993 Jul; 261(5117):82-6. PubMed ID: 8316859
[TBL] [Abstract][Full Text] [Related]
33. In vivo analysis of retroviral enhancer mutations in hematopoietic cells: SP1/EGR1 and ETS/GATA motifs contribute to long terminal repeat specificity.
Wahlers A; Zipfel PF; Schwieger M; Ostertag W; Baum C
J Virol; 2002 Jan; 76(1):303-12. PubMed ID: 11739695
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a functional ZBP-89 binding site that mediates Gata1 gene expression during hematopoietic development.
Ohneda K; Ohmori S; Ishijima Y; Nakano M; Yamamoto M
J Biol Chem; 2009 Oct; 284(44):30187-99. PubMed ID: 19723625
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the expression and function of the transcription factor PU.1 (Spi-1 proto-oncogene) between murine macrophages and B lymphocytes.
Ross IL; Dunn TL; Yue X; Roy S; Barnett CJ; Hume DA
Oncogene; 1994 Jan; 9(1):121-32. PubMed ID: 8302571
[TBL] [Abstract][Full Text] [Related]
36. Identification of a placental-specific enhancer in the rat placental lactogen II gene that contains binding sites for members of the Ets and AP-1 (activator protein 1) families of transcription factors.
Sun Y; Duckworth ML
Mol Endocrinol; 1999 Mar; 13(3):385-99. PubMed ID: 10076996
[TBL] [Abstract][Full Text] [Related]
37. Identification and characterization of an Alu-containing, T-cell-specific enhancer located in the last intron of the human CD8 alpha gene.
Hambor JE; Mennone J; Coon ME; Hanke JH; Kavathas P
Mol Cell Biol; 1993 Nov; 13(11):7056-70. PubMed ID: 8413295
[TBL] [Abstract][Full Text] [Related]
38. A minigene containing four discrete cis elements recapitulates GATA-1 gene expression in vivo.
Ohneda K; Shimizu R; Nishimura S; Muraosa Y; Takahashi S; Engel JD; Yamamoto M
Genes Cells; 2002 Dec; 7(12):1243-54. PubMed ID: 12485164
[TBL] [Abstract][Full Text] [Related]
39. An intron GATA-binding site regulates chromatin accessibility and is essential for IL-4 gene expression in mast cells.
Kwan M; Powell DR; Nachman TY; Brown MA
Eur J Immunol; 2005 Apr; 35(4):1267-74. PubMed ID: 15739164
[TBL] [Abstract][Full Text] [Related]
40. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
